RETSX
Price
$105.02
Change
-$0.59 (-0.56%)
Updated
Jul 13 closing price
Net Assets
12.65B
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

RETSX vs VSTSX

RETSX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
RETSX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RETSX is a Buy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. RETSX (12.6B). VSTSX pays higher dividends than RETSX: VSTSX (1.07) vs RETSX (0.41). RETSX was incepted earlier than VSTSX: RETSX (30 years) vs VSTSX (10 years). RETSX (0.90) is less costly to investors than VSTSX (0.01). RETSX is a more actively managed with annual turnover of: 31.00 vs. VSTSX (3.00). RETSX has a lower initial minimum investment than VSTSX: RETSX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. RETSX (18.46). VSTSX return over 5 years is better than : 66.56 vs. RETSX (63.23).
RETSXVSTSXRETSX / VSTSX
Total Expense Ratio0.900.019,000%
Annual Report Gross Expense Ratio0.900.019,000%
Fund Existence30 years10 years-
Gain YTD9.72511.20587%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets12.6B2.3T1%
Annual Yield % from dividends0.411.0738%
Returns for 1 year18.4621.4886%
Returns for 3 years61.6867.0692%
Returns for 5 years63.2366.5695%
Returns for 10 years225.72239.5394%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I